Introduction
============

Coronary heart disease (CHD) remains one of the leading causes of death in both genders in developed countries.[@b1-ARYA-11-233] The incidence of mortality due to cardiovascular disease has been diminishing over the previous 3 decades in many developed countries.[@b2-ARYA-11-233] Reduced incidences, promotion of secondary prevention measures, use of new treatments during the acute phase, and improved survival after myocardial infarction (MI) have contributed to the declining mortality rates.[@b3-ARYA-11-233]-[@b5-ARYA-11-233] However, MI is a primary cause of mortality and disability in the Iranian population.[@b6-ARYA-11-233] Age, sex, cardiovascular risk factors, coronary history, acute MI (AMI) location, complications, treatments received during hospitalization and after hospital discharge, and the type of hospital are among the variables that may influence early or late mortality following an AMI.[@b7-ARYA-11-233]-[@b10-ARYA-11-233]

Most of the centers showed a decline in short-term case fatality rate, but the Isfahan center, Iran, did not.[@b5-ARYA-11-233] The purpose of the present study was the analysis of the trends of case fatality rate of AMI in Isfahan and Najafabad based on gender, age groups, and type of AMI in patients treated during 2000-2009. Type of AMI was determined according to the International Classification of Disease, version 10 (ICD10) and using streptokinase.

Materials and Methods
=====================

Isfahan is a city in the center of Iran, an Eastern Mediterranean country, and is the second largest city of Iran. Previous studies have shown a relatively high rate of cardiovascular risk factors in this industrial city.[@b11-ARYA-11-233]-[@b15-ARYA-11-233]

During the study period, about 13 hospitals were admitting and managing patients with CHD in Isfahan. More than 75% of patients who had experienced MI were managed in 4 public hospitals and the rest in the remaining 9 private hospitals. Except for military hospitals, which did not allow access to their patients' records, other hospital records were evaluated. Among these hospitals, 4 were private and 9 public or university hospitals.[@b16-ARYA-11-233]

In this registry, all possible CHD events were registered disregarding the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) age limitation. In this study, the MONICA definition (non-fatal definite events and fatal definite or possible events) is used for MI events. Moreover, only first events and patients classified as one group according ICD10 are included.

The research team involved in the program consisted of cardiologists and general practitioners, a number of nurses trained in receiving and recording patients' information, and professional biostatistician and epidemiologist. Identification and separation of patients with AMI based on ICD10 was performed by a cardiologist. Hospital discharge lists were used for case finding. Records of patients hospitalized in cardiology wards, coronary care units, or other wards but under the complete or partial supervision of cardiologists, were evaluated for possible signs and symptoms of CHD events. Basic information related to patients were collected by trained nurses, who used special forms to interview patients or obtained information from their hospital records. Symptoms and cardiac enzymes codes were classified in a manner similar to the MONICA project.[@b17-ARYA-11-233] They summarized accurate records in special checklists containing in-formation on age, sex, event and hospitalization dates, symptoms, history of previous MI, enzymes, admission electrocardiogram, whether the event was iatrogenic, survival status at discharge and after 28 days follow-up, and whether thrombolytic therapy was used during hospitalization. An expert nurse with special training in the MONICA registration system checked the filled records. Moreover, 10% of the checklists were randomly chosen and refilled by the expert nurse using the original hospital records and compared with those completed by registered nurses to see if any mistakes occurred. Then, data was collected from the Isfahan Cardiovascular Research Center (ICRC). As the center of Isfahan Province, MI patients who live in other cities of the province are also admitted to these hospitals. In order to calculate MI survival rate in Isfahan, only records from Isfahan and Najafabad city inhabitants were included in the study.[@b16-ARYA-11-233]

A period of 28 days was used to define the case-fatality rate and to distinguish between events.[@b18-ARYA-11-233] All discharged MI patients were followed using telephone calls, and if not available, reached through their address. The patients or close family members were asked about patients' health status. If a patient had died during the first 28 days after the event, death scenario was asked.[@b16-ARYA-11-233] Detailed descriptions of the methods used in this project have been provided in previous reports.[@b16-ARYA-11-233],[@b19-ARYA-11-233]-[@b24-ARYA-11-233]

Overall, 14,450 patients (10,334 men and 4116 women) with first AMI, who were inhabitants of Isfahan and Najafabad were entered into the study. Subsequently, 886 patients (564 men and 322 women) were excluded because their AMI type was not determined according to the ICD10. Furthermore, 118 patients (82 men and 36 women) were exclude from the study, because they died during the 28 days after the first attack without any sign of cardiovascular disease and due to accident, suicide, homicide, chronic obstructive pulmonary disease, cancer, liver cirrhosis, rheumatic heart disease, vascular disease, or atherosclerosis. In addition, 418 patients (292 men and 126 women) were excluded because outcome was unknown. Moreover, 128 patients (89 men and 39 women) were excluded from the study, because the exact date of occurrence or death from the disease was not specified and the 28 days duration after the attack could not be calculated in these cases.[@b17-ARYA-11-233] Therefore, 12,900 patients, 9307 (72.15%) men and 3593 (27.85%) women, remained in the study.

The study period, from 2000 to 2009, was divided into 5 2-year periods (2000-2001, 2002-2003, 2004-2005, 2006-2007, and 2008-2009). Case fatality rates were adjusted for age through direct standardization. Standardization was based on 4 age groups; ≤ 40, 41-60, 61-80, and ≥ 81 years. In order to compare age average in the study, t-test and analysis of variance (ANOVA) were used. To assess the case fatality rate according to each period, Kaplan-Meier analysis, and to compare case fatality rate, log-rank test were used. Short-term (28 days) case fatality hazard ratio (HR) was calculated using the Cox regression model for every 2-year period. The first period (2000-2001) was considered as reference, and other periods were compared with this group and 95% confidence interval (CI) was calculated. The trend of streptokinase use in the treatment of AMI in hospitals was evaluated in every 2-year period. SPSS software (version 15, SPSS Inc., Chicago, IL, USA) was used for data analysis. The significance value was set to P \< 0.050.

Results
=======

In total, this study included 12,900 fatal and non-fatal first AMI events, of which 9307 (72.15%) were men and 3593 (27.85%) women. Sex ratio (male/female) was 2.59. Patient's demographic and clinical data is presented in [table 1](#t1-ARYA-11-233){ref-type="table"}. The distribution of first AMI and 28 days case fatality rate in 10 years (for every 2 years separately) of the study periods is shown in [table 2](#t2-ARYA-11-233){ref-type="table"}. Of the 12,900 patients with AMI entered into the study, 1198 died during the 28 days after their MI event (overall case fatality rate = 09.30% and survival rate = 90.70%). Of the 9307 men, 697 died (case fatality rate = 07.50% and survival rate = 92.50%) and of the 3593 women, 501 died (case fatality rate = 13.90% and survival rate = 86.10%) (P \< 0.001).

A steady descending trend was observed in the 28 days case fatality rate during the study period (2000-2009); it decreases from 11.82% in 2000-2001 to 07.90% in 2008-2009. In fact, we observed a 03.92% decrease in case fatality rate from 2000-2001 to 2008-2009, and 29.46% improvement in survival rate compared to 2000-2001. However, this trend has been in both genders. Therefore, in men, it decreased from 09.20% in 2000-2001 to 06.70% in 2008-2009 (meaning a 02.5% decrease in case fatality rate from 2000-2001 to 2008-2009 and 27.17% improvement in survival rate compared to 2000-2001). In women, it decreased from 16.10% in 2000-2001 to 10.90% in 2008-2009 (meaning a 05.20% decrease in case fatality rate from 2000-2001 to 2008-2009 and 36.80% improvement in survival rate compared to 2000-2001) ([Table 2](#t2-ARYA-11-233){ref-type="table"} and [Figure 1](#f1-ARYA-11-233){ref-type="fig"}).

However, this trend was observed in HR of 28 days case fatality rate from AMI during the study period. Thus, in comparison with 2000-2001, in 2002-2003, 2004-2005, 2006-2007, and 2008-2009, HR was 0.93 (CI 95% = 0.77-1.11), 0.88 (CI 95% = 0.73-1.04), 0.67 (CI 95% = 0.56-0.82), and 0.69 (CI 95% = 0.56-0.82), respectively. This trend was observable in both genders. In men, HR, respectively, was 0.98 (CI 95% = 0.74-1.30), 0.95 (CI 95% = 0.75-1.29), 0.73 (CI 95% = 0.54-0.98), and 0.67 (CI 95% = 0.49-0.91). In women, it was 0.91 (CI 95% = 0.72-1.15), 0.8 (CI 95% = 0.64-1.00), 0.66 (CI 95% = 0.51-0.84), and 0.71 (CI 95% = 0.56-0.92), respectively ([Table 2](#t2-ARYA-11-233){ref-type="table"}).

Mean age of all patients was 61.80 ± 12.60; in men it was 60.00 ± 12.50 and in women 66.72 ± 11.34. This difference was statically significant (P ≤ 0.0010). To examine changes in age of disease occurrence over time, the study period was divided into 5 2-year periods. Mean age of all patients increased from 61.36 ± 12.19 in the primary period (2000-2001) to 62.61 ± 12.81 in the final period (2008-2009). This difference was statically significant (P = 0.0070). There was a raising trend in mean age in men and women in the study period. For women, in the primary period, it was 65.38 ± 10.95 and in the final period was 67.15 ± 11.72 (P = 0.0200). For men, in the primary period, it was 59.75 ± 12.29 and in the final period 59.84 ± 12.54 (P = 0.0170) ([Table 3](#t3-ARYA-11-233){ref-type="table"}). In addition, this trend was observed in mean age at time of death. Thus, in the primary period, it was 68.00 ± 10.60 and in the final period, 71.40 ± 9.53 (P = 0.0200). This trend was observed in men and women, but it was only significant in women. For women, in the primary period, it was 68.86 ± 10.41 and in the final period, 73.11 ± 08.94 (P = 0.0440). For men, in the primary period, it was 67.40 ± 10.73, and in the final period, 70.31 ± 08.70 (P = 0.1640) ([Table 3](#t3-ARYA-11-233){ref-type="table"}).

[Table 4](#t4-ARYA-11-233){ref-type="table"} shows the trends of case fatality rate for each age group. Case fatality rate decreased in a steady pattern in all age groups with the increase in age. Consequently, there was a 60, 60, 19.31, and 46.75 percent reduction in case fatality rate in the final period (2008-2009), compared to the primary period (2000-2001), respectively, for \< 40, 41-60, 61-80, and \> 81 age groups ([Table 4](#t4-ARYA-11-233){ref-type="table"}).

In this study, based on ICD10, AMI was classified into 6 groups; acute transmural MI of anterior wall, acute transmural MI of inferior wall, acute transmural MI of other site, acute transmural MI of unspecified site, acute sub endocardial MI and AMI, and unspecified. Because the number of patients in acute transmural MI of other sites and acute transmural MI of unspecified site was small and very unstable, we considered these two groups as one group. In Isfahan and Najafabad, based ICD10, from 2000 to 2009 no evident trend was observed in 10 years case fatality rate. However, difference in average case fatality rate between types of AMI, according to ICD10, was statistically significant (P \< 0.0001) ([Table 5](#t5-ARYA-11-233){ref-type="table"}).

In addition, use of streptokinase in the treatment service during the study period had no clear trend. In average, 51.8% (minimum of 48.3% and maximum of 56.40%) of patients received streptokinase, 55.70% in men (minimum of 52.20% and maximum of 61.80%) and 41.70% in women (minimum of 38.20% and maximum of 44.70%). Furthermore, 48.20% (minimum of 43.60% and maximum of 51.70%) of patients did not receive streptokinase; 47.80% in men (minimum of 38.20% and maximum of 47.80%) and 61.80% in women (minimum of 55.30% and maximum of 61.80%) ([Table 6](#t6-ARYA-11-233){ref-type="table"}).

Discussion
==========

In the present study, we have demonstrated a consistent decrease in case fatality rate following a first MI in Isfahan, during a 10 years period from 2000 to 2009. The decreasing trend of case fatality rate was observable in both genders and all age groups. There was a 29.46% reduction in case fatality rate in the final period (2008-2009) compared with the primary period (2000-2001). A 27.17% decrease was observed in men, and 32.29% in women. Moreover, a 60% decrease in the ≤ 40 age group, 60% in 41-60 age group, 19.31% in 61-80, and 46.75% in ≥ 80 was observed. In addition, in the duration of the study, there was a decreasing trend in the HR of 28 days case fatality rate in all patients.

In this study, the majority of patients were men (72.10% men and 27.90% women) and women were older (66.77 ± 11.37 vs. 60.00 ± 12.54 years; P \< 0.0010). The 28 days case fatality rate was higher in women than men (13.90 vs. 07.50%; \< 0.0001). In a study conducted by Carine Milcent et al. in the French Hospitals Database, most patients were men (70% men and 30% women) and women were older (75 vs. 63 years of age; P \< 0.0010) and had a higher rate of hospital mortality (14.80 vs. 06.10%; P \< 0.0001) than men.[@b25-ARYA-11-233] This was in agreement with the findings of the current study. However, the present analysis confirms the higher 28 days case fatality rate from AMI in women; the so-called "gender gap" reported in other studies.[@b26-ARYA-11-233]-[@b29-ARYA-11-233] In previous studies, we observed that crude hospital mortality rates for AMI in women was higher than men. This difference may be partly due to the higher average age of women at the time of disease occurrence and higher prevalence of comorbidities in women compared with men.[@b26-ARYA-11-233] More frequent use of revascularization procedures in men may also account for the fewer deaths. Indeed, men with AMI tend to undergo more aggressive hospital treatments than women.[@b30-ARYA-11-233],[@b31-ARYA-11-233] We observed a similar result in the Iranian treatment system; during the study, an average higher proportion of men received streptokinase than women (55.70% men and 41.70% women). However, the impact of lower rates of revascularization is controversial. In some studies, older age and higher baseline risk are presented as the causes of higher rates of mortality in women.[@b32-ARYA-11-233],[@b33-ARYA-11-233] In addition, some studies inferred that treatment in women had no effect on short-term survival from AMI.[@b27-ARYA-11-233],[@b34-ARYA-11-233] Case fatality rate of AMI in 2008-2009 was 29.46% less than in 2000-2001 (in men 27.17% and in women 32.29%), which coincides with the results of other hospital registered studies.[@b35-ARYA-11-233]-[@b37-ARYA-11-233] HR of 28 days case fatality rate of AMI in 2008-2009 was 0.69 (95% CI = 0.56-0.82) compared with 2000-2001; for men and women, it was 0.63 (95% CI = 0.45-0.88) and 0.70 (95% CI = 0.54-0.90), respectively. A similar result was obtained in a European register on acute coronary syndrome, that compared 30 days mortality in 2000 and 2004 \[odds ratio (OR) = 0.85 (0.73-0.99)\].[@b38-ARYA-11-233] In the study by MacIntyre et al., 28 days case fatality rate increased with increasing of age.[@b39-ARYA-11-233] However, in this study, with the rising trend in mean age in the disease occurrence a steady decline was observed in case fatality rate. It is evident that the severity of infarctions decreased over time. A hypothesis is that the increasing use of medications such as aspirin and β-blockers before admission may reduce the size and severity of infarctions.[@b40-ARYA-11-233] Therefore, over time this could be effective in reducing the AMI case fatality rate.

Population-based studies all documented a favorable decline in early mortality among younger individuals contrasting with a persistently high fatality rate among the elderly over a period of time ranging from 1975 to 1995.[@b2-ARYA-11-233],[@b41-ARYA-11-233]-[@b44-ARYA-11-233] More importantly, the mortality rate of infarction in the community remained high and was consistently higher than that reported in clinical trials, reflecting their inherent selection processes.[@b45-ARYA-11-233] Although only clinical trials can test the efficacy of a new treatment, reports from community surveillance present important complementary insights into the effectiveness of care and treatments once implement. The current study demonstrates that the marked improvement in early fatalities after MI persisted over time and that notable survival gains were realized among the women and elderly, in whom discrepancy had been detected previously.[@b43-ARYA-11-233] This article was conducted based on the MONICA project in Isfahan with the support and ethical approval of ICRC with the code 84130, in year 2012.

***Limitations***

A difficulty of this study is a lack of complete, community-based case ascertainment, which includes protocols for finding community fatal and non-fatal MI cases who are not admitted to hospitals. Most important limitation of the study is the lack of data about out-of-hospital fatal cases, such as MI cases managed at home or in health centers. This figure might be unimportant since MI event is considered an emergency in the Iranian health care system, and all hospitals should admit such patients regardless of their insurance status. In the Danish MONICA population, this figure was measured to be \> 01% of total MI cases in a year.[@b46-ARYA-11-233] Therefore, omitting these patients will not lead to a sham decline in MI case fatality rates.

Conclusion
==========

We have demonstrated a consistent decrease in case fatality rate following a first MI in Isfahan, during a 10-year period from 2000 to 2009. The decrease in the trend of case fatality rate in both genders and all age groups was observable. There was 29.46% reduction in case fatality rate in the final period (2008-2009) compared to the primary period (2000-2001); 27.17% in men and 32.29% in women. A 60%, 60%, 19.31%, and 46.75% reduction was observed in the ≤ 40 years, 41-60 years, 61-80 years, and ≥ 80 years age groups, respectively.
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###### 

Demographic and clinical data of hospitalized myocardial infarction (MI) patients in Isfahan

  Variables                                  Men    Women   Total                                      
  ------------------------------------------ ------ ------- ------- ------ ----- ------ ------- ------ -------
  Age in men                                                                                           
   39 year and lower                         427    98      525     336    114   450    763     212    975
   40-49                                     394    5       399     42     2     44     436     7      443
   50-59                                     1587   42      1629    225    11    236    1812    53     1865
   60-69                                     2423   102     2525    579    48    627    3002    150    3152
   70-79                                     2150   193     2343    933    123   1056   3083    316    3399
   80 year and older                         1629   257     1886    977    203   1180   2606    460    3066
  Streptokinase                                                                                        
   Receiving                                 4864   317     5181    1269   229   1498   6133    546    6679
   Not receiving                             3746   380     4126    1823   272   2095   5569    652    6221
  ICD, version 10                                                                                      
   Acute sub endocardial MI                  2979   213     3192    950    126   1076   3929    339    4268
   Acute transmural MI of other sites        2650   109     2759    825    86    911    3475    195    3670
   Acute transmural MI of inferior wall      225    7       232     84     11    95     309     18     327
   Acute transmural MI of anterior wall      82     24      106     28     25    53     110     49     159
   AMI, unspecified                          736    16      752     446    20    466    1182    36     1218
   Acute transmural MI of unspecified site   1938   328     2266    759    233   992    2697    561    3258
  The first center was referred                                                                        
   Non-specialized hospitals                 573    65      638     185    53    238    758     118    876
   Specialized hospital                      7547   590     8137    2747   418   3165   10294   1008   11302
   Unknown                                   208    27      235     66     14    80     274     41     315
   Health networker clinic                   282    15      297     94     16    110    376     31     407
  Symptoms                                                                                             
   Typical                                   7250   523     7773    2518   380   2898   9768    903    10671
   A typical                                 993    92      1085    376    48    424    1369    140    1509
   Others                                    339    75      414     183    69    252    522     144    666
   Miss                                      28     7       35      15     4     19     43      11     54
  Cardiac enzymes                                                                                      
   A typical                                 1026   61      1087    509    66    575    1535    127    1662
   Typical                                   6597   483     7080    2196   306   2502   8793    789    9582
   Others                                    780    45      825     291    43    334    1071    88     1159
   Not clear                                 207    108     315     96     86    182    303     194    497
  Hospital                                                                                             
   Academic hospitals                        7894   650     8544    2842   465   3307   10736   1115   11851
   Privative hospitals                       716    47      763     250    36    286    966     83     1049

ICD: International Classification of Diseases; Cardiac enzymes: Lactate dehydrogenase, creatine kinase, and Troponin

###### 

Trend of case fatality rate of acute myocardial infarction (AMI) according to gender in Isfahan and Najafabad from 2000 to 2009

  Years        Total (n)   Number of events   Case fatality rate   HR of case fatality (95% CI)
  ------------ ----------- ------------------ -------------------- ------------------------------
  Men                                                              
   Overall     9307        697                7.5                  \-
   2000-2001   1331        123                9.2                  R
   2002-2003   1877        159                8.5                  0.98 (0.74-1.30)
   2004-2005   2208        166                7.5                  0.98 (0.75-1.29)
   2006-2007   2029        125                6.2                  0.73 (0.54-0.98)
   2008-2009   1862        124                6.7                  0.67 (0.49-0.91)
  Women                                                            
   Overall     3593        501                13.9                 \-
   2000-2001   533         86                 16.1                 R
   2002-2003   719         112                15.6                 0.91 (0.72-1.15)
   2004-2005   893         139                15.6                 0.81 (0.64-1.00)
   2006-2007   725         85                 11.7                 0.66 (0.51-0.84)
   2008-2009   723         79                 10.9                 0.71 (0.56-0.92)
  Total                                                            
   Overall     12900       1198               09.3                 \-
   2000-2001   1864        209                11.2                 R
   2002-2003   2596        271                10.4                 0.93 (0.77-1.11)
   2004-2005   3101        305                09.8                 0.88 (0.73-1.04)
   2006-2007   2754        210                07.6                 0.67 (0.56-0.82)
   2008-2009   2585        203                07.9                 0.69 (0.57-0.84)

R: Reference group; HR: Hazard ratio; CI: Confidence interval

###### 

Trend of change in mean age of patients with acute myocardial infarction (AMI) at time of occurrence and death in Isfahan and Najafabad from 2000 to 2009

  Years                       Number of men   Mean age in men   P       Number of women   Mean age in women   P               Number of patients   Mean age in patients   P       Sex ratio (men/women)
  --------------------------- --------------- ----------------- ------- ----------------- ------------------- --------------- -------------------- ---------------------- ------- -----------------------
  Age of disease occurrence                                                                                                                                                       
   Overall                    9307            60.00 ± 12.54     0.017   3593              66.77 ± 11.37       0.020           12900                61.90 ± 12.60          0.007   2.59
   2000-2001                  1331            59.75 ± 12.29     533     65.38 ± 10.95     1864                61.36 ± 12.19   2.49                                                
   2002-2003                  1877            59.77 ± 12.44     719     66.89 ± 11.14     2596                61.74 ± 12.51   2.61                                                
   2004-2005                  2208            59.60 ± 12.59     893     66.62 ± 11.45     3101                61.62 ± 12.68   2.47                                                
   2006-2007                  2029            60.13 ± 12.50     725     67.46 ± 11.34     2754                62.06 ± 12.63   2.79                                                
   2008-2009                  1862            59.84 ± 12.54     723     67.15 ± 11.72     2585                62.61 ± 12.81   2.57                                                
  Age in death time                                                                                                                                                               
   Overall                    697             68.12 ± 11.15     0.164   501               71.46 ± 10.27       0.044           1198                 69.52 ± 10.91          0.020   1.40
   2000-2001                  123             67.40 ± 10.73     86      68.86 ± 10.41     209                 68.00 ± 10.60   1.43                                                
   2002-2003                  159             67.16 ± 11.30     112     71.27 ± 10.58     271                 68.86 ± 11.17   1.41                                                
   2004-2005                  166             67.94 ± 11.20     139     71.40 ± 10.52     305                 69.51 ± 11.00   1.19                                                
   2006-2007                  125             68.13 ± 12.40     85      72.90 ± 10.12     210                 70.06 ± 11.74   1.47                                                
   2008-2009                  124             70.31 ± 8.70      79      73.11 ± 08.94     203                 71.40 ± 09.53   1.56                                                

###### 

Trend of case fatality rate of acute myocardial infarction (AMI) according to age groups in Isfahan and Najafabad from 2000 to 2009

  Age group (year)   \< 40   41-60   61-80   \> 81                                               
  ------------------ ------- ------- ------- ------- ----- ----- ------ ----- ------ ----- ----- ------
  Overall            556     11      1.97    5323    225   4.2   6285   804   12.8   736   159   21.6
  2000-2001          87      2       2.30    734     47    6.4   985    143   14.5   58    17    29.3
  2002-2003          119     4       3.40    1048    56    5.3   1309   175   13.4   120   36    30.0
  2004-2005          146     1       0.70    1333    59    4.4   1456   205   14.1   166   40    24.1
  2006-2007          96      3       3.10    1163    36    3.1   1315   138   10.5   180   33    18.3
  2008-2009          108     1       0.90    1045    26    2.5   1220   143   11.7   212   33    15.6

###### 

Trend of case fatality rate of acute myocardial infarction (AMI) according to type of AMI based on the International Classification of Diseases 10 (ICD10) in Isfahan and Najafabad from 2000 to 2009

  AMI based ICD10   Acute transmural MI of anterior wall   Acute transmural MI of inferior wall   Acute transmural MI of other sites and acute transmural MI of unspecified site   Acute subendocardial MI   unspecified AMI   Total                                                        
  ----------------- -------------------------------------- -------------------------------------- -------------------------------------------------------------------------------- ------------------------- ----------------- ------- ----------- ----- ------------ ------ -------------- ------
  Overall           4268 (339)                             9.1                                    3670 (195)                                                                       5.3                       486 (67)          13.8    1218 (36)   3.0   3258 (561)   17.2   12900 (1198)   09.3
  2000-2001         74 (69)                                9.5                                    602 (40)                                                                         6.6                       192 (46)          24.0    200 (10)    5.0   145 (44)     30.3   1864 (209)     11.2
  2002-2003         94 (98)                                9.9                                    836 (60)                                                                         7.2                       90 (8)            08.9    260 (6)     2.3   416 (99)     23.8   2596 (271)     10.4
  2004-2005         996 (75)                               5.0                                    888 (44)                                                                         5.0                       102 (6)           05.9    269 (2)     0.7   846 (178)    21.0   3101 (305)     09.8
  2006-2007         762 (40)                               5.2                                    707 (30)                                                                         4.2                       74 (5)            06.8    265 (7)     2.6   946 (128)    13.5   2754 (210)     07.6
  2008-2009         791 (57)                               7.2                                    637 (21)                                                                         3.3                       28 (2)            07.1    24 (11)     4.9   905 (112)    12.4   2585 (203)     07.9

AMI: Acute myocardial infarction; MI: Myocardial infarction; ICD10: International Classification of Diseases 10

###### 

Trend of use of streptokinase in treatment of acute myocardial infarction (AMI) according to gender in Isfahan and Najafabad from 2000 to 2009

  Streptokinase   Men           Women         Total                                                                             
  --------------- ------------- ------------- ------------ ------------- ------------- ------------ ------------- ------------- -------------
  Overall         5181 (55.7)   4126 (47.8)   9307 (100)   1498 (41.7)   2095 (58.3)   3593 (100)   6679 (51.8)   6221 (48.2)   12900 (100)
  2000-2001       823 (61.8)    508 (38.2)    1331 (100)   229 (43.0)    304 (57.0)    533 (100)    1052 (56.4)   812 (43.6)    1864 (100)
  2002-2003       1022 (54.4)   855 (45.6)    1877 (100)   291 (40.5)    428 (59.5)    719 (100)    1313 (50.6)   1283 (49.4)   2596 (100)
  2004-2005       1267 (57.4)   941 (42.6)    2208 (100)   399 (44.7)    494 (55.3)    893 (100)    1666 (53.7)   1435 (47.3)   3101 (100)
  2006-2007       1097 (54.1)   932 (45.9)    2029 (100)   303 (41.8)    422 (58.2)    725 (100)    1400 (50.8)   1354 (49.2)   2754 (100)
  2008-2009       972 (52.2)    890 (47.8)    1862 (100)   276 (38.2)    447 (61.8)    723 (100)    1248 (48.3)   1337 (51.7)   2585 (100)
